NCT02344043View on ClinicalTrials.gov

Cerebral Oxygenation and Neurological Outcomes FOllowing CriticAL Illness

CompletedOBSERVATIONAL

Enrollment

116

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions

Critical IllnessSepsisDeliriumRespiratory Failure

Interventions

DEVICE

Near infrared spectroscopy

This device uses near infrared spectroscopy to measure tissue oxygen levels (0-100%). The sensors are placed on the subjects' forehead to measure brain tissue oxygenation

Trial Locations (1)

K7L3V7

Kingston General Hospital, Kingston

All Listed Sponsors

lead

Queen's University

OTHER

NCT02344043 - Cerebral Oxygenation and Neurological Outcomes FOllowing CriticAL Illness | Biotech Hunter | Biotech Hunter